引用本文
  •    [点击复制]
  •    [点击复制]
PDF HTML全文阅读
本文已被:浏览 1867次   下载 1200 本文二维码信息
码上扫一扫!
四妙丸治疗血栓性浅静脉炎的网络药理学机制研究
公瑞,刘湘,张玥,程志新,殷璇
山东中医药大学济南250014;山东中医药大学附属医院济南250014;山东省济南市公安交警支队济南250014
摘要:
目的:通过网络药理学方法对四妙丸治疗血栓性浅静脉炎(STP)的作用机制进行探索。方法:通过中药系统药理数据库和分析平台(TCMSP)筛选四妙丸所含的有效成分并预测其作用靶点;通过GeneCards、OMIM、CTD等数据库筛选出STP的相关靶点,将成分作用靶点与疾病靶点取交集得到交集靶点,利用Cytoscape 3.7.2软件构建中药复方-成分靶点-疾病网络图,通过String数据库构建蛋白-蛋白相互作用(PPI)网络;利用ClueGO插件对四妙丸治疗STP进行GO功能和KEGG通路富集分析,并选取部分化合物和靶点进行分子对接验证。结果:获得四妙丸60个有效成分,132个潜在靶点,STP 4148个靶点,GO Biological Process分析得到214条生物过程,KEGG分析得到29条通路。分子对接结果显示槲皮素、β-谷甾醇与雄激素受体(AR)、雌激素受体1(ESR1)、凝血酶Ⅱ(F2)有良好对接活性。结论:四妙丸可能通过槲皮素(MOL000098)、β谷甾醇(MOL000358)等有效成分作用于ESR1、AR、F2等靶点以及白细胞介素-17(IL-17)信号通路、肿瘤坏死因子(TNF)信号通路、松弛素(RLX)信号通路及C型凝集素受体(CLR)信号通路等通路的抗炎、保护血管内皮细胞的作用来治疗STP,体现了四妙丸治疗STP多分子、多靶点、多通路的协同作用机制,为后续深入探讨四妙丸治疗STP的分子机制提供理论依据。
关键词:  四妙丸  血栓性浅静脉炎  网络药理学  分子对接  机制
DOI:10.3969/j.issn.1007-6948.2022.01.017
投稿时间:2021-03-21
基金项目:国家自然科学基金面上项目(81774311),山东省中医药科技发展计划项目(2013-053)
Study on Network Pharmacological Mechanism of Simiao Pills in Treating Superficial Thrombophlebitis
GONG Rui,LIU Xiang,ZHANG Yue
Abstract:
Objective To explore the mechanism of Simiao pill in treating superficial thrombophlebitis (STP) by network pharmacology. Methods The Chinese medicine system pharmacology technology platform (TCMSP) database was used to screen the effective components of Simiao pill and predict its target. The relevant targets of STP were selected through GeneCards, OMIM, CTD and other databases. The intersection targets were obtained by intersecting the component action targets with disease targets. The TCM compound-component-targetdisease network diagram was constructed using Cytoscape 3.7.2 software, and the protein-protein interaction (PPI) network was constructed through String database. GO function and KEGG pathway enrichment analysis were performed for Simiao pill treatment of STP using the ClueGO plugin, and some compounds and targets were selected for molecular docking validation. Results 60 active ingredients, 132 potential targets of Simiao pills and 4148 targets of STP were obtained. 214 biological processes were obtained from GO Biological Process analysis, and 29 pathways were obtained from KEGG analysis. Molecular docking results showed that quercetin and β-sitosterol had good docking activity with AR, ESR1 and F2. Conclusion Simiao pills may treat STP by acting on androgen receptor (AR), estrogen receptor 1 (ESR1), thrombin II (F2) and other targets as well as the role of interleukin-17 (IL-17) signaling pathway, tumor necrosis factor (TNF) signaling pathway, relaxin (RLX) signaling pathway and C-type lectin receptor (CLR) signaling pathway and protecting vascular endothelial cells through the active ingredients such as mistletoe bombesin (MOL000098) and β-sitosterol (MOL000358), reflecting the synergistic mechanism of Simiao pills in the treatment of STP with multiple molecules, multiple targets and multiple pathways, providing a theoretical basis for the subsequent in-depth discussion of the molecular mechanism of Simiao pills in the treatment of STP.
Key words:  Simiao pill  superficial thrombophlebitis  network pharmacology  molecular docking  mechanism

用微信扫一扫

用微信扫一扫